Effect of curcumin on amyloid-like aggregates generated from methionine-oxidized apolipoprotein A-I
- Univ. of California, Berkeley, CA (United States). Dept. of Nutritional Sciences and Toxicology
- Children's Hospital Oakland Research Inst., Oakland, CA (United States); Univ. of Tehran (Iran). Dept. of Biotechnology and College of Science
- Children's Hospital Oakland Research Inst., Oakland, CA (United States)
- Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States). The Molecular Foundry
- Univ. of California, Berkeley, CA (United States). Dept. of Nutritional Sciences and Toxicology; Children's Hospital Oakland Research Inst., Oakland, CA (United States); Univ. of Nevada, Reno, NV (United States). Dept. of Biochemistry and Molecular Biology
Curcumin is a polyphenolic phytonutrient that has antineurodegenerative properties. Here, we investigated the anti-amyloidogenic properties of curcumin. Following incubation with curcumin, intrinsic tryptophan fluorescence emission of apolipoprotein (apo) A-I was strongly quenched. At the same time, curcumin fluorescence emission was enhanced. The fluorescence emission spectra of curcumin in the presence of amyloid-like aggregates formed by methionine-oxidized (ox) apoA-I varied, depending on whether curcumin was added before, or after, aggregate formation. The impact of curcumin on the structure of the aggregating material was revealed by the lower amount of β-structure in ox-apoA-I amyloid-like aggregates formed in the presence of curcumin, compared to aggregates formed without curcumin. However, the kinetics of ox-apoA-I amyloid-like aggregate formation was not altered by the presence of curcumin. Moreover, electron microscopy analysis detected no discernable differences in amyloid morphology when ox-apoA-I amyloid-like aggregates were formed in the presence or absence of curcumin. In conclusion, curcumin interacts with apoA-I and alters the structure of ox-apoA-I amyloid-like aggregates yet does not diminish the propensity of ox-apoA-I to form aggregates.
- Research Organization:
- Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States)
- Sponsoring Organization:
- USDOE Office of Science (SC), Basic Energy Sciences (BES); National Institutes of Health (NIH)
- Grant/Contract Number:
- AC02-05CH11231; R37‐HL64159; R01‐HL113059; HL115153; GM104427
- OSTI ID:
- 1416461
- Alternate ID(s):
- OSTI ID: 1416605; OSTI ID: 1433116
- Journal Information:
- FEBS Open Bio, Vol. 8, Issue 2; Related Information: © 2017 The Authors. Published by FEBS Press and John Wiley & Sons Ltd.; ISSN 2211-5463
- Country of Publication:
- United States
- Language:
- English
Web of Science
Renal expression of JAK2 is high in polycystic kidney disease and its inhibition reduces cystogenesis
|
journal | March 2019 |
Renal expression of JAK2 is high in polycystic kidney disease and its inhibition reduces cystogenesis
|
journal | March 2019 |
Similar Records
Preformed {beta}-amyloid fibrils are destabilized by coenzyme Q{sub 10} in vitro
Ferulic acid destabilizes preformed {beta}-amyloid fibrils in vitro